Endometrial cancer
The landscape reflects a shift toward immune checkpoint blockade and combination therapy strategies, with some clinical trials demonstrating promising efficacy.
The landscape reflects a shift toward immune checkpoint blockade and combination therapy strategies, with some clinical trials demonstrating promising efficacy.
CONTRIBUTION: Provides a global overview of research output and clinical trial activity in endometrial cancer immunotherapy, highlighting the increasing emphasis on checkpoint inhibitors and combination regimens, thereby informing future research priorities and clinical practice.
Evidence level: Klinikai vizsgálat. Formális klinikai vizsgálati eredmény.
Related signals
- Immunotherapy improves endometrial cancer outcomes
- Quality of Life Measures in Advanced Endometrial Cancer: A Systematic Review of Reporting Practices in Phase III Clinical Trials
- Endometrial Cancer - PMC
- Current recommendations and recent progress in endometrial cancer
- Advancements in Endometrial Cancer Research in 2024